National Breast and Cervical Cancer Early Detection Program

National Breast and Cervical Cancer Early Detection Program
Name	National Breast and Cervical Cancer Early Detection Program
Formed	1990
Jurisdiction	United States
Headquarters	Atlanta, Georgia
Parent department	Centers for Disease Control and Prevention
Website	https://www.cdc.gov/cancer/nbccedp/

National Breast and Cervical Cancer Early Detection Program. This public health initiative is administered by the Centers for Disease Control and Prevention to provide access to critical screening services for low-income, uninsured, and underinsured individuals across the United States. Established by an act of the United States Congress, the program forms partnerships with state and territorial health agencies, as well as American Indian and Alaska Native organizations, to deliver breast and cervical cancer screenings and diagnostic follow-up. Its creation was a direct legislative response to documented disparities in cancer mortality and has since become a cornerstone of the nation's efforts to reduce the burden of these diseases through early detection.

Background and history

The program was established following the passage of the **Breast and Cervical Cancer Mortality Prevention Act of 1990**, which was signed into law by President George H. W. Bush. This legislative action was driven by growing public health data from organizations like the American Cancer Society and the National Cancer Institute highlighting significant survival disparities linked to late-stage diagnosis, particularly among socioeconomically disadvantaged groups. Prior to its creation, many low-income women faced substantial barriers to receiving routine mammograms and Pap tests, leading to higher mortality rates from otherwise treatable cancers. The program's inception marked a major federal commitment to addressing these inequities through organized, state-based screening efforts.

Program structure and administration

The Centers for Disease Control and Prevention serves as the national administrator, providing funding, technical assistance, and oversight. Implementation occurs through cooperative agreements with all 50 states, the District of Columbia, 5 U.S. territories, and 13 tribes or tribal organizations through the **National Breast and Cervical Cancer Early Detection Program**. These grantees, which include state health departments like the California Department of Public Health and the New York State Department of Health, adapt the program to local needs while adhering to federal guidelines. Each grantee operates a network of clinical providers, which may include Federally Qualified Health Centers, local health departments, and hospital systems, to deliver standardized screening services.

Eligibility and services provided

Eligibility is primarily based on income, insurance status, and age, with specific criteria set by individual grantees within federal parameters. The program typically serves individuals with incomes at or below 250% of the federal poverty level who lack adequate insurance coverage. Core clinical services include screening mammograms, clinical breast exams, Pap tests, and HPV tests. If abnormalities are detected, the program also covers essential diagnostic services such as diagnostic mammography, breast ultrasound, biopsy, and colposcopy. Importantly, the program facilitates access to treatment through linkages with the **Breast and Cervical Cancer Prevention and Treatment Act**, which provides Medicaid coverage.

Impact and outcomes

Since its launch, the program has provided over 16 million screening exams to more than 6 million people, diagnosing thousands of invasive breast cancers, cervical cancers, and precancerous cervical lesions. Surveillance data analyzed by the Centers for Disease Control and Prevention and published in journals like Morbidity and Mortality Weekly Report demonstrate that the program has successfully reached its target population, contributing to a reduction in advanced-stage diagnoses among participants. These efforts align with broader national health objectives outlined in initiatives like **Healthy People 2030** and have informed screening guidelines developed by the United States Preventive Services Task Force.

Funding and legislation

Initial funding was authorized by the **Breast and Cervical Cancer Mortality Prevention Act of 1990**. A pivotal subsequent law, the **Breast and Cervical Cancer Prevention and Treatment Act of 2000**, signed by President Bill Clinton, allowed states to offer Medicaid coverage for treatment to those diagnosed through the program. Annual appropriations are determined by the United States Congress, often through the work of committees like the House Committee on Appropriations. Program funding is also influenced by advocacy from groups such as the American College of Obstetricians and Gynecologists and the National Association of County and City Health Officials.

Partnerships and collaborations

The program's success relies on a vast network of partnerships beyond its state and tribal grantees. It collaborates extensively with national organizations like the American Cancer Society, the National Association of Chronic Disease Directors, and the Association of State and Territorial Health Officials to promote screening and professional education. At the community level, partnerships with entities like the YMCA and various American Indian and Alaska Native health boards help conduct outreach and patient navigation. These collaborations are essential for public education campaigns, quality assurance of clinical services, and implementing evidence-based interventions recommended by the Community Preventive Services Task Force.

Category:Health programs in the United States Category:Centers for Disease Control and Prevention Category:Cancer screening